Cipla appoints Prabhakaran Balakrishnan Nair as Global Chief Manufacturing Officer Ruchika Sharma2 Jun 2025 2:40 PM ISTMumbai: Cipla has announced the appointment of Prabhakaran Balakrishnan Nair, presently working as Chief of Quality - Indore plant, as Senior...
Cipla (EU), UK incorporates new wholly owned subsidiary in Germany Ruchika Sharma1 Jun 2025 5:48 PM ISTMumbai: Cipla has announced that Cipla (EU) Limited, UK, a wholly owned subsidiary of the Company, has incorporated a new wholly owned subsidiary...
USFDA issues one observation for Cipla Bommasandra facility Ruchika Sharma31 May 2025 11:30 AM ISTMumbai: Cipla has announced that the United States Food and Drugs Administration (USFDA) has concluded the inspection with one observation at the...
Cipla arm to acquire 26% stake in AMPIN Energy C&I Eighteen Ruchika Sharma20 May 2025 5:23 PM ISTMumbai: Pharmaceutical giant Cipla Ltd. has announced that Jay Precision Pharmaceuticals Private Limited, a subsidiary of the Company, will acquire...
Cipla arm Mahape facility gets VAI status from USFDA Ruchika Sharma19 May 2025 11:00 AM ISTMumbai: Cipla has announced that the United States Food and Drugs Administration (USFDA) has classified the current Good Manufacturing Practices...
Cipla arm Medispray Goa facility classified as VAI by USFDA Ruchika Sharma18 April 2025 3:05 PM ISTMumbai: Cipla has announced that the United States Food and Drug Administration (USFDA) has classified the inspection at the manufacturing...
Cipla gets USFDA nod for Paclitaxel Protein bound Particles for Injectable Suspension Ruchika Sharma11 April 2025 11:30 AM ISTMumbai: Cipla has announced that the Company has received final approval from the United States Food and Drug Administration (USFDA) for the ...
Cipla gets exclusive rights to market ophthalmic drug across 11 countries Ruchika Sharma20 March 2025 1:30 PM ISTAPP13007 is a novel, patent protected and USFDA approved ophthalmic product.
USFDA issues 2 observations for Cipla arm Mahape facility Ruchika Sharma21 Feb 2025 1:30 PM ISTMumbai: Cipla, an Indian multinational pharmaceutical company, has announced that the United States Food and Drugs Administration...
Cipla bags USFDA nod for chronic myeloid leukemia drug Nilotinib Ruchika Sharma21 Feb 2025 11:30 AM ISTMumbai: Pharma major, Cipla, has received final approval from the United States Food and Drug Administration (USFDA) for the New Drug...
Cipla completes investment of ZAR 900 million in South Africa subsidiary Ruchika Sharma19 Feb 2025 4:56 PM ISTMumbai: Cipla Limited has announced that the Company has completed an investment of approx. ZAR 900 million in Cipla Medpro South Africa...
Cipla gets VAI status for Virgonagar facility Ruchika Sharma8 Feb 2025 1:30 PM ISTMumbai: Cipla has announced that the United States Food and Drug Administration (USFDA) has classified the inspection at the Company’s manufacturing...
